This was the stock's second consecutive day of losses.

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a ...

Viral infectious diseases pose significant challenges due to the rapid evolution of viruses through mutations. This was particularly evident during the COVID-19 pandemic, when emerging variants of ...

Simulation-driven engineering is no longer a niche capability; it is foundational to innovation and competitive advantage.